Medical cannabis, also known simply as medicinal marijuana, refers to any cannabis and certain Cannabinoids legally prescribed by doctors for terminally ill patients. The therapeutic value of this cannabis is being debated by various government bodies and medical experts. Medical cannabis is used to relieve the pain experienced by terminally ill patients with cancer, AIDS, Glaucoma, and other debilitating conditions. Patients with Crohn’s disease or severe arthritis can also benefit from medical cannabis. It has been used extensively to treat AIDS patients and other ailments.
Recent research suggests that medical marijuana is effective in treating PTSD in adults. This is the first time that anyone has reported positive results from medical cannabis use in a patient suffering from PTSD. The University of Wisconsin Madison was the site of the study. The subjects who were involved in the study were veterans who had PTSD due to their post-traumatic stress disorder. The PTSD patients were given marijuana to help them cope with their symptoms.
These results were recently published in the peer-reviewed Journal of the American Medical Association. Researchers from the University of Wisconsin Madison reported that patients suffering from PTSD experienced significant improvements in their moods and other mental health issues after receiving medicinal cannabis. The use of cannabis had a significantly lower impact on patients’ overall health, and well-being. This is the first time medical cannabis has been approved for use in clinical trials for post-traumatic stress disorder.
The study tested two different types of pharmaceuticals that are believed to be effective in treating PTSD with high CBD and low THC content. It found that there were no differences in the placebo effect between the two groups. However, the researchers did find that there were some differences in the way the different pharmaceuticals affects the body when consumed. Both CBD and opioids possess anti-emetic qualities and reduce nausea in patients suffering from PTSD. Patients with PTSD are most commonly affected by nausea and vomiting. While there may be some benefit in reducing nausea and vomiting, the opioids’ lessening effect on the body may limit its effectiveness as an antiemetic agent. This may explain why more recent studies are aiming to test other pharmaceuticals and CBD derivatives for additional development into a viable treatment for PTSD.
Recent news reports in Canada, the United States and Europe have raised questions about the safety of medical cannabis. The three countries have very different laws regarding the use of cannabis for medicinal purposes. In Canada, doctors can recommend the use of medical cannabis as an alternative to prescription drugs. The government has issued a variety of guidelines and warning labels to inform patients and caregivers about the potential risks of medical cannabis use. Medical cannabis users in the United States and Europe are often prescribed powerful synthetic drugs to counter the side effects of cannabis.
Recently, Canadian provinces have begun to examine the possibility of legalising medical cannabis production and distribution. Both the Canadian and American provincial governments are investigating the legality of cannabis use. Provinces that have legalized medical cannabis have been slower to develop a framework governing the production, sale and regulation of the drug. To ensure consistency in the use and production of medical cannabis across Canada, the Canadian government has maintained its commitment to regulation. Some patients have had to choose from pharmacies that cannot supply their prescriptions, due to the new system that requires that pharmacies sell only supplies of medical cannabis.
Canada’s government stated that it will introduce legislation allowing for the cultivation, production, distribution and sale of medical marijuana. With the introduction of Canada’s Drug Controlled Products Act, a focus has been placed on consumer safety. This law will allow the government the to ban the importation, distribution and production of certain pharmaceuticals that may have an impact on the health or well-being of people who are using medical cannabis. Due to the potential for tainted components, Ephedra and Herbal Extracts from China and Mexico are currently illegal. Other affected pharmaceuticals include pain management devices, chemotherapy drugs and asthma inhalers.
The Controlled Substances Act, which makes it illegal for anyone to distribute, produce or sell any Schedule II or Schedule III controlled substance, was passed in the U.S. House of Representatives in 2012. The Controlled Substances Act also makes it illegal to possess any such substance if one has not been granted valid consent to use it for medicinal purposes. Some states have made distinctions between recreational and medical cannabis. Canada has made a distinction between legal and medical cannabis by declaring that the drug serves a medical purpose. This means that persons who grow and supply cannabis that has been authorized by the Government of Canada for medical purposes are not breaking the law.